- Home
- LPA vs COYA Comparison
LPA vs COYA Comparison
Compare LPA & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LPA | COYA |
|---|---|---|
| Founded | 2013 | 2020 |
| Country | Costa Rica | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.3M | 102.7M |
| IPO Year | 2023 | 2022 |
Fundamental Metrics
Financial Performance| Metric | LPA | COYA |
|---|---|---|
| Price | $2.42 | $3.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | $7.00 | ★ $15.21 |
| AVG Volume (30 Days) | 23.0K | ★ 166.4K |
| Earning Date | 11-10-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,945,753.00 |
| Revenue This Year | $14.11 | N/A |
| Revenue Next Year | $10.81 | $335.89 |
| P/E Ratio | $11.25 | ★ N/A |
| Revenue Growth | N/A | ★ 123.57 |
| 52 Week Low | $2.04 | $2.72 |
| 52 Week High | $4.38 | $6.62 |
Technical Indicators
Market Signals| Indicator | LPA | COYA |
|---|---|---|
| Relative Strength Index (RSI) | 35.77 | 38.12 |
| Support Level | $2.33 | $2.72 |
| Resistance Level | $2.72 | $5.17 |
| Average True Range (ATR) | 0.11 | 0.35 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 15.22 | 36.71 |
Price Performance
Historical ComparisonAbout LPA Logistic Properties of the Americas
Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns, and manages a diversified portfolio of warehouse logistics assets in Central America and South America. It focuses on modern Class A logistics real estate in high-growth and high-barrier-to-entry markets that are undersupplied and have low penetration rates. The company has four operating segments, based on geographic regions, consisting of Colombia, Peru, Mexico and Costa Rica. The company generates the majority of its revenue from the Costa Rica geographical segment.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.